CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
52 hedge funds and large institutions have $83.8M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
67% less capital invested
Capital invested by funds: $253M → $83.8M (-$170M)
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.7M | |
| 2 | +$553K | |
| 3 | +$461K | |
| 4 |
Millennium Management
New York
|
+$389K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$332K |
Top Sellers
| 1 | -$4.46M | |
| 2 | -$3.63M | |
| 3 | -$2.04M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$1.4M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.12M |